Enzyme Replacement Therapy Market

Enzyme Replacement Therapy Market: Injectable Expected to be the Most Preferred Route of Administration: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Ask The Analyst Customization Available Request Methodology

A rare disease is defined as a disease that affects a small percentage of the general population. Drugs used for the treatment of rare diseases are called orphan drugs. Enzyme Replacement Therapy (ERT) is the treatment for rare diseases. According Global genes.org, 80% of rare diseases are of genetic origin. There are approximately 7,000 different types of rare diseases. Approximately 50% of the people affected by rare diseases are children. According to the Kakkis Every life Foundations, FDA-approved drugs are not available for 95% of rare diseases. ERT replaces an enzyme that is absent in the body. ERT is available for diseases such as fabry disease, gaucher disease, mucopolysaccharidosis, Pompe disease, and lysosomal acid lipase deficiency, among others.

The report classifies the global ERT market by therapeutic condition, route of administration, distribution channels, and regions.

Market Value and Forecast

The global ERT market is expected to grow at a CAGR of 6.5% over the forecast period of 2018–2028 to reach US$ 13,776.2 Mn by 2028. By country, the U.S. dominated North America ERT market and is expected to be the most lucrative market in the region.

Market Dynamics

Increase in healthcare expenditure and prevalence of rare diseases are among prime factors driving the ERT market. Growth in the demand for ERT to improve the treatment of rare diseases is anticipated to drive the market over the forecast period. Increase in government spending on healthcare infrastructure, such as favorable reimbursement for ERT, is expected to boost the market. In addition, socioeconomic factors such as increase in the prevalence of rare diseases, are among factors driving the market globally.

However, availability of alternative treatment options, dearth of skilled healthcare professionals, and lack of regulatory framework in emerging economics are some of the factors expected to restrain market growth over the forecast period.

Market Segmentation by Therapeutic Condition

Based on therapeutic condition, global ERT market has been segmented into fabry disease, gaucher disease, mucopolysaccharidosis, Pompe disease, lysosomal acid lipase deficiency, and others. Among these, the lysosomal acid lipase deficiency segment is anticipated to register the highest CAGR of 7.5% over the forecast period. The mucopolysaccharidosis segment is expected to register a market share of 24.0% in 2028.

Market Segmentation by Route of Administration

Route of administration of ERT covered in this report includes oral and injectable. The injectable segment held the highest market share and this trend is expected to continue over the forecast period owing to increase in the demand for injectable ERT drugs. In addition, this segment is expected to register a market share of 86.6% in 2028.

global enzyme replacement therapy market

Market Segmentation by Distribution Channel

Distribution channels of ERT covered in this report include hospital pharmacies, specialty treatment pharmacies, and retail pharmacies. The specialty treatment pharmacies segment held the largest market share and this trend is expected to continue over the forecast period. The hospital pharmacies segment is also anticipated to occupy a significant market share over the forecast period.

Key Regions

Geographically, the global ERT market has been segmented into eight major regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China and Japan (APEJ), China, Japan, and Middle East & Africa (MEA). In terms of revenue, North America has been estimated to account for the highest share of the global ERT market with approximately 25%-30% by the end of 2017. On the other hand, revenue from the market in Western Europe is expected to grow significantly at a CAGR of 5.4% over the forecast period.

This Future Market Insights report examines the ‘Enzyme Replacement Therapy Market’ for the period 2013–2017 and provides forecasts for 2018–2028. The primary objective of the report is to offer updates and in-depth analysis of the global market opportunities for Enzyme Replacement Therapy (ERT).

Increase in the global demand for ERT for the treatment of rare diseases is anticipated to drive the market over the forecast period. Increase in government spending on healthcare infrastructure such as favourable reimbursement for ERT is expected to boost the global market. Growth in the number of research initiatives with the help of non-profit organisations and increase in government support are also among factors expected to fuel market growth.

However, the availability of alternative treatment options and high treatment cost are some of the factors that are expected to hamper the growth of the global market. Dearth of skilled healthcare professionals and lack of regulatory framework in emerging economics are also likely to restrain the global market over the forecast period.

The global enzyme replacement therapy market has been segmented on the basis of:

  • Therapeutic Conditions

  • Route of Administration

  • Distribution Channels

  • Regions

The report analyses the global ERT market in terms of value (US$ Mn). The report begins with the definition of the market and explains different therapeutic conditions. The market viewpoint section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro factors that influence the global market. Opportunity analysis provided in this section equips clients with crystal clear decision-making insights.

The report analyses the market based on regions and presents the forecast in terms of value for the next 10 years. Regions covered in the report include:

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific excluding China & Japan (APECJ)

  • China

  • Japan

  • Middle East & Africa (MEA)

Each of these sections analyse regional markets by therapeutic condition, route of administration, distribution channels and country. The regional market dynamics section provides key growth trends pertaining to each region. The representative market participants section consists of a list of companies that operate in different regions, competitive landscape and intensity map of their presence in each region.

Weighted average selling price is considered to estimate the market size of various devices mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures are converted into USD to offer forecasts in a consistent currency standard. Furthermore, FMI also considers the latest annual exchange rate to reflect the impact of the most recent economic conditions of country. Prices considered in these models are standardised based on the average cost per ERT.

The forecast presented in the report provides total revenue of approved ERT over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, a ‘Competitive Landscape’ is included to provide a dashboard view and to access the key differentiators among competitor firms. This section is primarily designed to provide clients an objective and detailed comparative assessment of product offerings and strategies of key providers specific to market segments. Detailed profiles of market players are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to the market and strategic overview.

The next section of report analyses the market based on therapeutic conditions and presents the forecast in terms of value for the next 10 years. Therapeutic conditions covered in the report include:

  • Fabry Disease

  • Gaucher Disease

  • Mucopolysaccharidosis

    • MPS I

    • MPS II (Hunter syndrome)

    • MPS IVA (Morquio syndrome, type A)

    • MPS VI (Maroteaux-Lamy syndrome)

    • MPS VII (Sly syndrome)

  • Pompe Disease

  • Lysosomal Acid Lipase Deficiency

  • Others

The next section of report analyses the market based on the route of administration of ERT and provides forecast in terms of value for the next 10 years. On the basis of route of administration, the market is segmented into:

  • Oral

  • Injectable

The next section of report analyses the market based on the distribution channels of ERT and provides forecast in terms of value for the next 10 years. On the basis of distribution channel, the market is segmented into:

  • Hospital Pharmacies

  • Specialty Treatment Pharmacies

  • Retail Pharmacies

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve as well as to identify potential resources from a sales and delivery perspective of products. To understand key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis that helps clients identify real market opportunities.

Enzyme Replacement Therapy Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Enzyme Replacement Therapy Market View Point Analysis

3.1. Macro-Economic Factors

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Trends

3.3. Opportunity Analysis

3.4. Value Chain Analysis

4. Macroeconomic Assumptions

5. Global Economic Outlook

5.1. Gross Domestic Product by Region & Country, 2006 – 2021

5.2. Global Pharmaceutical Market Outlook

6. Key Inclusions

6.1. Rare Disease Framework

6.2. Orphan Drug Key Regulations, By Country

6.3. Pipeline Assessment of Enzyme Replacement Therapy

7. North America Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

7.3.1. U.S.

7.3.2. Canada

7.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

7.5. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

7.5.1. Fabry Disease

7.5.2. Gaucher Disease

7.5.3. Mucopolysaccharidosis

7.5.3.1. MPS I

7.5.3.2. MPS II (Hunter syndrome)

7.5.3.3. MPS IVA (Morquio syndrome, type A)

7.5.3.4. MPS VI (Maroteaux-Lamy syndrome)

7.5.3.5. MPS VII (Sly syndrome)

7.5.4. Pompe Disease

7.5.5. Lysosomal acid lipase Deficiency

7.5.6. Others

7.6. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

7.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

7.7.1. Oral

7.7.2. Injectable

7.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

7.9.1. Hospital Pharmacies

7.9.2. Specialty Treatment Pharmacies

7.9.3. Retail Pharmacies

7.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

7.11. Market Attractiveness Analysis

7.11.1. By Country

7.11.2. By Therapeutic Condition

7.11.3. By Route of Administration

7.11.4. By Distribution Channel

7.12. Drivers and Restraints: Impact Analysis

7.13. Key Market Participants – Intensity Mapping

8. Latin America Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Trends

8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

8.3.1. Brazil

8.3.2. Mexico

8.3.3. Rest of Latin America

8.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

8.5. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

8.5.1. Fabry Disease

8.5.2. Gaucher Disease

8.5.3. Mucopolysaccharidosis

8.5.3.1. MPS I

8.5.3.2. MPS II (Hunter syndrome)

8.5.3.3. MPS IVA (Morquio syndrome, type A)

8.5.3.4. MPS VI (Maroteaux-Lamy syndrome)

8.5.3.5. MPS VII (Sly syndrome)

8.5.4. Pompe Disease

8.5.5. Lysosomal acid lipase Deficiency

8.5.6. Others

8.6. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

8.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

8.7.1. Oral

8.7.2. Injectable

8.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

8.9.1. Hospital Pharmacies

8.9.2. Specialty Treatment Pharmacies

8.9.3. Retail Pharmacies

8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

8.11. Market Attractiveness Analysis

8.11.1. By Country

8.11.2. By Therapeutic Condition

8.11.3. By Route of Administration

8.11.4. By Distribution Channel

8.12. Drivers and Restraints: Impact Analysis

8.13. Key Market Participants – Intensity Mapping

9. Western Europe Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Trends

9.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

9.3.1. Germany

9.3.2. U.K

9.3.3. France

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Western Europe

9.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

9.5. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

9.5.1. Fabry Disease

9.5.2. Gaucher Disease

9.5.3. Mucopolysaccharidosis

9.5.3.1. MPS I

9.5.3.2. MPS II (Hunter syndrome)

9.5.3.3. MPS IVA (Morquio syndrome, type A)

9.5.3.4. MPS VI (Maroteaux-Lamy syndrome)

9.5.3.5. MPS VII (Sly syndrome)

9.5.4. Pompe Disease

9.5.5. Lysosomal acid lipase Deficiency

9.5.6. Others

9.6. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

9.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

9.7.1. Oral

9.7.2. Injectable

9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

9.9.1. Hospital Pharmacies

9.9.2. Specialty Treatment Pharmacies

9.9.3. Retail Pharmacies

9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

9.11. Market Attractiveness Analysis

9.11.1. By Country

9.11.2. By Therapeutic Condition

9.11.3. By Route of Administration

9.11.4. By Distribution Channel

9.12. Drivers and Restraints: Impact Analysis

9.13. Key Market Participants – Intensity Mapping

10. Eastern Europe Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Trends

10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

10.3.1. Russia

10.3.2. Poland

10.3.3. Rest of Eastern Europe

10.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

10.5. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

10.5.1. Fabry Disease

10.5.2. Gaucher Disease

10.5.3. Mucopolysaccharidosis

10.5.3.1. MPS I

10.5.3.2. MPS II (Hunter syndrome)

10.5.3.3. MPS IVA (Morquio syndrome, type A)

10.5.3.4. MPS VI (Maroteaux-Lamy syndrome)

10.5.3.5. MPS VII (Sly syndrome)

10.5.4. Pompe Disease

10.5.5. Lysosomal acid lipase Deficiency

10.5.6. Others

10.6. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

10.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

10.7.1. Oral

10.7.2. Injectable

10.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

10.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

10.9.1. Hospital Pharmacies

10.9.2. Specialty Treatment Pharmacies

10.9.3. Retail Pharmacies

10.10.  Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

10.11.  Market Attractiveness Analysis

10.11.1. By Country

10.11.2. By Therapeutic Condition

10.11.3. By Route of Administration

10.11.4. By Distribution Channel

10.12.  Drivers and Restraints: Impact Analysis

10.13.  Key Market Participants – Intensity Mapping

11. Asia Pacific Excluding China & Japan Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

11.1. Introduction

11.2. Regional Market Trends

11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

11.3.1. India

11.3.2. Australia and New Zealand

11.3.3. ASEAN

11.3.4. Rest of APECJ

11.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

11.5. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

11.5.1. Fabry Disease

11.5.2. Gaucher Disease

11.5.3. Mucopolysaccharidosis

11.5.3.1. MPS I

11.5.3.2. MPS II (Hunter syndrome)

11.5.3.3. MPS IVA (Morquio syndrome, type A)

11.5.3.4. MPS VI (Maroteaux-Lamy syndrome)

11.5.3.5. MPS VII (Sly syndrome)

11.5.4. Pompe Disease

11.5.5. Lysosomal acid lipase Deficiency

11.5.6. Others

11.6. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

11.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

11.7.1. Oral

11.7.2. Injectable

11.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

11.9.1. Hospital Pharmacies

11.9.2. Specialty Treatment Pharmacies

11.9.3. Retail Pharmacies

11.10.  Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

11.11.  Market Attractiveness Analysis

11.11.1. By Country

11.11.2. By Therapeutic Condition

11.11.3. By Route of Administration

11.11.4. By Distribution Channel

11.12.  Drivers and Restraints: Impact Analysis

11.13.  Key Market Participants – Intensity Mapping

12. China Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

12.2.1. Fabry Disease

12.2.2. Gaucher Disease

12.2.3. Mucopolysaccharidosis

12.2.3.1. MPS I

12.2.3.2. MPS II (Hunter syndrome)

12.2.3.3. MPS IVA (Morquio syndrome, type A)

12.2.3.4. MPS VI (Maroteaux-Lamy syndrome)

12.2.3.5. MPS VII (Sly syndrome)

12.2.4. Pompe Disease

12.2.5. Lysosomal acid lipase Deficiency

12.2.6. Others

12.3. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

12.4. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

12.4.1. Oral

12.4.2. Injectable

12.5. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

12.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

12.6.1. Hospital Pharmacies

12.6.2. Specialty Treatment Pharmacies

12.6.3. Retail Pharmacies

12.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

12.8. Market Attractiveness Analysis

12.8.1. By Therapeutic Condition

12.8.2. By Route of Administration

12.8.3. By Distribution Channel

12.9. Drivers and Restraints: Impact Analysis

12.10.  Key Market Participants – Intensity Mapping

13. Japan Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

13.2.1. Fabry Disease

13.2.2. Gaucher Disease

13.2.3. Mucopolysaccharidosis

13.2.3.1. MPS I

13.2.3.2. MPS II (Hunter syndrome)

13.2.3.3. MPS IVA (Morquio syndrome, type A)

13.2.3.4. MPS VI (Maroteaux-Lamy syndrome)

13.2.3.5. MPS VII (Sly syndrome)

13.2.4. Pompe Disease

13.2.5. Lysosomal acid lipase Deficiency

13.2.6. Others

13.3. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

13.4. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

13.4.1. Oral

13.4.2. Injectable

13.5. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

13.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

13.6.1. Hospital Pharmacies

13.6.2. Specialty Treatment Pharmacies

13.6.3. Retail Pharmacies

13.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

13.8. Market Attractiveness Analysis

13.8.1. By Therapeutic Condition

13.8.2. By Route of Administration

13.8.3. By Distribution Channel

13.9. Drivers and Restraints: Impact Analysis

13.10.  Key Market Participants – Intensity Mapping

14. Middle East and Africa Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

14.1. Introduction

14.2. Regional Market Trends

14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

14.3.1. GCC Countries

14.3.2. South Africa

14.3.3. Rest of Middle East and Africa

14.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

14.5. Historical Market Size (US$ Mn) Trend Analysis By Therapeutic Condition, 2013-2017

14.5.1. Fabry Disease

14.5.2. Gaucher Disease

14.5.3. Mucopolysaccharidosis

14.5.3.1. MPS I

14.5.3.2. MPS II (Hunter syndrome)

14.5.3.3. MPS IVA (Morquio syndrome, type A)

14.5.3.4. MPS VI (Maroteaux-Lamy syndrome)

14.5.3.5. MPS VII (Sly syndrome)

14.5.4. Pompe Disease

14.5.5. Lysosomal acid lipase Deficiency

14.5.6. Others

14.6. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

14.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017

14.7.1. Oral

14.7.2. Injectable

14.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

14.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

14.9.1. Hospital Pharmacies

14.9.2. Specialty Treatment Pharmacies

14.9.3. Retail Pharmacies

14.10.  Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

14.11.  Market Attractiveness Analysis

14.11.1. By Country

14.11.2. By Therapeutic Condition

14.11.3. By Route of Administration

14.11.4. By Distribution Channel

14.12.  Drivers and Restraints: Impact Analysis

14.13.  Key Market Participants – Intensity Mapping

15. Forecast Factors: Relevance and Impact

16. Market Structure Analysis

16.1. Market Structure by Tier

16.2. Market Share Analysis (2017) for Top 10 Players, By Region

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Profitability and Gross Margin Analysis By Competition

17.4. Competitors Deep Dive

17.4.1. Sanofi S.A. (Genzyme Corporation)

17.4.1.1. Overview

17.4.1.2. Product and Application Portfolio

17.4.1.3. Production Footprint

17.4.1.4. Sales Footprint

17.4.1.5. Channel Footprint

17.4.1.6. Strategy

17.4.1.6.1. Marketing Strategy

17.4.1.6.2. Product Strategy

17.4.1.6.3. Channel Strategy

17.4.2. Shire plc.

17.4.2.1. Overview

17.4.2.2. Product and Application Portfolio

17.4.2.3. Production Footprint

17.4.2.4. Sales Footprint

17.4.2.5. Channel Footprint

17.4.2.6. Strategy

17.4.2.6.1. Marketing Strategy

17.4.2.6.2. Product Strategy

17.4.2.6.3. Channel Strategy

17.4.3. Pfizer Inc.

17.4.3.1. Overview

17.4.3.2. Product and Application Portfolio

17.4.3.3. Production Footprint

17.4.3.4. Sales Footprint

17.4.3.5. Channel Footprint

17.4.3.6. Strategy

17.4.3.6.1. Marketing Strategy

17.4.3.6.2. Product Strategy

17.4.3.6.3. Channel Strategy

17.4.4. Alexion Pharmaceuticals, Inc.

17.4.4.1. Overview

17.4.4.2. Product and Application Portfolio

17.4.4.3. Production Footprint

17.4.4.4. Sales Footprint

17.4.4.5. Channel Footprint

17.4.4.6. Strategy

17.4.4.6.1. Marketing Strategy

17.4.4.6.2. Product Strategy

17.4.4.6.3. Channel Strategy

17.4.5. BioMarin Pharmaceutical Inc.

17.4.5.1. Overview

17.4.5.2. Product and Application Portfolio

17.4.5.3. Production Footprint

17.4.5.4. Sales Footprint

17.4.5.5. Channel Footprint

17.4.5.6. Strategy

17.4.5.6.1. Marketing Strategy

17.4.5.6.2. Product Strategy

17.4.5.6.3. Channel Strategy

17.4.6. Ultragenyx Pharmaceutical Inc.

17.4.6.1. Overview

17.4.6.2. Product and Application Portfolio

17.4.6.3. Production Footprint

17.4.6.4. Sales Footprint

17.4.6.5. Channel Footprint

17.4.6.6. Strategy

17.4.6.6.1. Marketing Strategy

17.4.6.6.2. Product Strategy

17.4.6.6.3. Channel Strategy

17.4.7. Johnson & Johnson Services, Inc.

17.4.7.1. Overview

17.4.7.2. Product and Application Portfolio

17.4.7.3. Production Footprint

17.4.7.4. Sales Footprint

17.4.7.5. Channel Footprint

17.4.7.6. Strategy

17.4.7.6.1. Marketing Strategy

17.4.7.6.2. Product Strategy

17.4.7.6.3. Channel Strategy

17.4.8. Allergan plc.

17.4.8.1. Overview

17.4.8.2. Product and Application Portfolio

17.4.8.3. Production Footprint

17.4.8.4. Sales Footprint

17.4.8.5. Channel Footprint

17.4.8.6. Strategy

17.4.8.6.1. Marketing Strategy

17.4.8.6.2. Product Strategy

17.4.8.6.3. Channel Strategy

17.4.9. Leadiant Biosciences, Inc.

17.4.9.1. Overview

17.4.9.2. Product and Application Portfolio

17.4.9.3. Production Footprint

17.4.9.4. Sales Footprint

17.4.9.5. Channel Footprint

17.4.9.6. Strategy

17.4.9.6.1. Marketing Strategy

17.4.9.6.2. Product Strategy

17.4.9.6.3. Channel Strategy

18. Global Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027 By Region

18.1. Introduction / Key Findings

18.2. Historical Market Size (US$ Mn) Analysis By Region

18.2.1. North America

18.2.2. Latin America

18.2.3. Western Europe

18.2.4. Eastern Europe

18.2.5. Asia Pacific Excluding Japan And China

18.2.6. China

18.2.7. Japan

18.2.8. Middle East and Africa

18.3. Market Size (US$ Mn) Forecast By Region

18.4. Market Attractiveness Analysis By Region

19. Global Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027, By Therapeutic Condition

19.1. Introduction/Key Finding

19.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Condition, 2013-2017

19.2.1. Fabry Disease

19.2.2. Gaucher Disease

19.2.3. Mucopolysaccharidosis

19.2.3.1. MPS I

19.2.3.2. MPS II (Hunter syndrome)

19.2.3.3. MPS IVA (Morquio syndrome, type A)

19.2.3.4. MPS VI (Maroteaux-Lamy syndrome)

19.2.3.5. MPS VII (Sly syndrome)

19.2.4. Pompe Disease

19.2.5. Lysosomal acid lipase Deficiency

19.2.6. Others

19.3. Market Size (US$ Mn) Forecast By Therapeutic Condition, 2018-2028

19.4. Market Attractiveness Analysis By Therapeutic Condition

20. Global Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration

20.1. Introduction/Key Finding

20.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013-2017

20.2.1. Oral

20.2.2. Injectable

20.3. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028

20.4. Market Attractiveness Analysis By Route of Administration

21. Global Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

21.1. Introduction/Key Finding

21.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017

21.2.1. Hospital Pharmacies

21.2.2. Specialty Treatment Pharmacies

21.2.3. Retail Pharmacies

21.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

21.4. Market Attractiveness Analysis By Distribution Channel

22. Global Enzyme Replacement Therapy Market Analysis 2012–2016 and Forecast 2017–2027

22.1. Market Value Share Analysis By All Segment

22.2. Y-o-Y Growth Analysis By All Segment

22.3. Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Enzyme Replacement Therapy Market Reports - List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: Comparison of orphan drug regulation across the US, Europe, Japan, Korea, Taiwan and China, 2017

Table 04: Enzyme Replacement Therapy Clinical Trials 

Table 05: Enzyme Replacement Therapy Clinical Trials 

Table 06: Enzyme Replacement Therapy Clinical Trials 

Table 07: Enzyme Replacement Therapy Clinical Trials 

Table 08: Enzyme Replacement Therapy Clinical Trials 

Table 09: Enzyme Replacement Therapy Clinical Trials 

Table 10: Enzyme Replacement Therapy Clinical Trials 

Table 11: Enzyme Replacement Therapy Clinical Trials 

Table 12: Enzyme Replacement Therapy Clinical Trials 

Table 13: Enzyme Replacement Therapy Clinical Trials 

Table 14: Enzyme Replacement Therapy Clinical Trials 

Table 15: Enzyme Replacement Therapy Clinical Trials 

Table 16: Enzyme Replacement Therapy Clinical Trials 

Table 17: Enzyme Replacement Therapy Clinical Trials 

Table 18: North America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 19: North America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 20: North America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 21: North America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 22: North America Enzyme Replacement Therapy Market Company Intensity Map

Table 23: Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 24: Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 25: Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 26: Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 27: Latin America Enzyme Replacement Therapy Market Company Intensity Map

Table 28: Budget Impact Of Orphan Drugs In Western European Countries

Table 29: Western Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 30: Western Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 31: Western Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 32: Western Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 33: Western Europe Enzyme Replacement Therapy Market Company Intensity Map

Table 34: Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 35: Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 36: Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 37: Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 38: Eastern Europe Enzyme Replacement Therapy Market Company Intensity Map

Table 39: National Initiatives to support rare diseases and access to orphan drugs in Southeast Asia, 2016 

Table 40: APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 41: APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 42: APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 43: APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 44: APECJ Enzyme Replacement Therapy Market Company Intensity Map

Table 45: Comparison of China orphan drug policies with other several major countries

Table 46: China Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 47: China Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 48: China Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 49: China Enzyme Replacement Therapy Market Company Intensity Map

Table 50: Japan Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 51: Japan Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 52: Japan Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 53: Japan Enzyme Replacement Therapy Market Company Intensity Map

Table 54: MEA Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 55: MEA Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 56: MEA Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 57: MEA Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Table 58: MEA Enzyme Replacement Therapy Market Company Intensity Map

Table 59: Global Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region

Table 60: Global Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Therapeutic Condition

Table 61: Global Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route of Administration

Table 62: Global Enzyme Replacement Therapy Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel 

Enzyme Replacement Therapy Market Reports - List of Figures

Figure 01: Enzyme Replacement Therapy Market Value Share By Region (2018)

Figure 02: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 03: North America Enzyme Replacement Therapy Market Value Share (2017A), By Country

Figure 04: North America Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 05: North America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 06: North America Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 07: North America Enzyme Replacement Therapy Market Y-o-Y growth (%) Comparison, By Country, 2018-2028

Figure 08: U.S. Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 09: U.S. Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 10: Canada Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 11: Canada Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 12: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 13: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 14: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 15: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 16: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 17: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 18: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 19: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 20: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 21: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 22: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 23: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 24: North America Enzyme Replacement Therapy Market Attractiveness Analysis, By Country

Figure 25: North America Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 26: North America Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 27: North America Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 28: Latin America Enzyme Replacement Therapy Market Value Share (2017A), By Country

Figure 29: Latin America Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 30: Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 31: Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 32: Latin America Enzyme Replacement Therapy Market Y-o-Y growth (%) Comparison, By Country, 2018-2028

Figure 33: Brazil Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 34: Brazil Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 35: Mexico Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 36: Mexico Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 37: Rest of Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 38: Rest of Latin America Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 39: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 40: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 41: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 42: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 43: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 44: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 45: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 46: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 47: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 48: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 49: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 50: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 51: Latin America Enzyme Replacement Therapy Market Attractiveness Analysis, By Country

Figure 52: Latin America Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 53: Latin America Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 54: Latin America Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 55: Western Europe Enzyme Replacement Therapy Market Value Share (2017A), By Country

Figure 56: Western Europe Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 57: Western Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 58: Western Europe Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 59: Western Europe Enzyme Replacement Therapy Market Y-o-Y growth (%) Comparison, By Country, 2018-2028

Figure 60: Germany Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 61: Germany Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 62: U.K. Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 63: U.K. Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 64: France Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 65: France Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 66: Italy Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 67: Italy Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 68: Spain Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 69: Spain Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 70: Rest of Western Europe  Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 71: Rest of Western Europe  Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 72: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 73: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 74: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 75: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 76: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 77: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 78: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 79: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 80: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 81: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 82: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 83: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 84: Western Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Country

Figure 85: Western Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 86: Western Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 87: Western Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 88: Eastern Europe Enzyme Replacement Therapy Market Value Share (2017A), By Country

Figure 89: Eastern Europe Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 90: Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 91: Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 92: Eastern Europe Enzyme Replacement Therapy Market Y-o-Y growth (%) Comparison, By Country, 2018-2028

Figure 93: Russia Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 94: Russia Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 95: Poland Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 96: Poland Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 97: Rest of Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 98: Rest of Eastern Europe Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 99: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 100: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 101: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 102: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 103: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 104: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 105: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 106: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 107: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 108: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 109: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 110: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 111: Eastern Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Country

Figure 112: Eastern Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 113: Eastern Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 114: Eastern Europe Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 115: APECJ Enzyme Replacement Therapy Market Value Share (2017A), By Country

Figure 116: APECJ Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 117: APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 118: APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 119: APECJ Enzyme Replacement Therapy Market Y-o-Y growth (%) Comparison, By Country, 2018-2028

Figure 120: India Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 121: India Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 122: Australia & NZ Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 123: Australia & NZ Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 124: ASEAN Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 125: ASEAN Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 126: Rest of APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 127: Rest of APECJ Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 128: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 129: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 130: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 131: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 132: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 133: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 134: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 135: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 136: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 137: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 138: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 139: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 140: APECJ Enzyme Replacement Therapy Market Attractiveness Analysis, By Country

Figure 141: APECJ Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 142: APECJ Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 143: APECJ Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 144: China Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 145: China Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 146: China Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 147: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 148: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 149: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 150: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 151: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 152: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 153: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 154: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 155: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 156: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 157: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 158: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 159: China Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 160: China Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 161: China Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 162: Japan Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 163: Japan Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 164: Japan Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 165: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 166: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 167: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 168: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 169: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 170: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 171: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 172: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 173: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 174: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 175: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 176: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 177: Japan Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 178: Japan Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 179: Japan Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 180: MEA Enzyme Replacement Therapy Market Value Share (2017A), By Country

Figure 181: MEA Enzyme Replacement Therapy Market Value Share (2017A), By Therapeutic Condition, Route of Administration and Distribution Channel

Figure 182: MEA Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 183: MEA Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 184: MEA Enzyme Replacement Therapy Market Y-o-Y growth (%) Comparison, By Country, 2018-2028

Figure 185: GCC Countries Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 186: GCC Countries Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 187: South Africa & NZ Enzyme Replacement Therapy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 188: South Africa Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 189: Rest of MEA Enzyme Replacement Therapy Market Size (US$ Mn) Analysis, 2013-2017

Figure 190: Rest of MEA Enzyme Replacement Therapy Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 191: Fabry Disease Market Size (US$ Mn) Analysis, 2013-2017

Figure 192: Fabry Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 193: Gaucher Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 194: Gaucher Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 195: Mucopolysaccharidosis Market Size (US$ Mn) Analysis, 2013-2017

Figure 196: Mucopolysaccharidosis Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 197: Pompe Disease Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 198: Pompe Disease Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 199: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Analysis, 2013-2017

Figure 200: Lysosomal acid lipase Deficiency Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 201: Others Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

Figure 202: Others Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

Figure 203: MEA Enzyme Replacement Therapy Market Attractiveness Analysis, By Country

Figure 204: MEA Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 205: MEA Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 206: MEA Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel 

Figure 207: Revenue Contribution by Tier Type (2017)

Figure 208: Global Enzyme Replacement Therapy Market Share (%) Analysis

Figure 209: Global Enzyme Replacement Therapy Market Attractiveness Analysis, By Region

Figure 210: Global Enzyme Replacement Therapy Market Attractiveness Analysis, By Therapeutic Condition

Figure 211: Global Enzyme Replacement Therapy Market Attractiveness Analysis, By Route of Administration 

Figure 212: Global Enzyme Replacement Therapy Market Attractiveness Analysis, By Distribution Channel

Figure 213: Global Enzyme Replacement Therapy Market Size and Y-o-Y, 2013 - 2017

Figure 214: Global Enzyme Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 215: Global Enzyme Replacement Therapy Market Absolute $ Opportunity, 2013–2028